selected scholarly activity
-
academic article
- Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population. Proceedings of the American Thoracic Society. 15:827-836. 2018
- Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012–2015. Canadian Journal of Allergy and Clinical Immunology Allergy, Asthma and Clinical Immunology. 13:10. 2017
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 1:103-111. 2017
- Cystic fibrosis: past, present, future. Dr. Andreas Freitag in an interview with Dr. Roman Jaeschke. Polskie Archiwum Medycyny Wewnetrznej. 127:73-75. 2017
- Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:128. 2016
- Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis. Annals of Intensive Care. 6:18. 2016
- Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:80. 2016
- The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Critical Care Critical Care. 20:75. 2016
- Implementation of a cystic fibrosis lung transplant referral patient decision aid in routine clinical practice: an observational study. Implementation Science. 10:17. 2015
- Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. Journal of Cystic Fibrosis. 14:755-762. 2015
- Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis. 14:262-266. 2015
- New data on noninvasive ventilation in stable chronic obstructive pulmonary disease: revolutionary or evolutionary?. Polskie Archiwum Medycyny Wewnetrznej. 125:5-7. 2015
- Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial. Journal of Critical Care. 29:470.e7-470.e15. 2014
- Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis. Intensive Care Medicine. 39:2115-2125. 2013
- Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis. Chest. 144:1207-1215. 2013
- Complications From Recruitment Maneuvers in Patients With Acute Lung Injury: Secondary Analysis From the Lung Open Ventilation Study. Respiratory Care. 57:1842-1849. 2012
- Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study. PLoS ONE. 7:e36077-e36077. 2012
- High-frequency oscillation in adults: A utilization review*. Critical Care Medicine. 39:2631-2644. 2011
- Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis. JAMA - Journal of the American Medical Association. 304:2145-2145. 2010
- Randomized Trial of a Decision Aid for Patients with Cystic Fibrosis Considering Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 180:761-768. 2009
- Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskeletal Disorders. 9:125. 2008
- Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial). Chest. 134:794-800. 2008
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 168:1805-1805. 2008
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors. Critical Care Critical Care. 12:R32-R32. 2008
- The Efficiency of Sputum Cell Counts in Cystic Fibrosis. Canadian Respiratory Journal. 14:99-103. 2007
- Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax. 61:969-974. 2006
- Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. Journal of Critical Care. 20:364-372. 2005
- Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. The Lancet. 366:463-471. 2005
- Glycemic control in the ICU: a multicenter survey. Intensive Care Medicine. 30:798-803. 2004
- Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study. BMC Musculoskeletal Disorders. 4:13. 2003
- Withdrawal of Mechanical Ventilation in Anticipation of Death in the Intensive Care Unit. New England Journal of Medicine. 349:1123-1132. 2003
- α1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease. American Journal of Respiratory Cell and Molecular Biology. 29:390-396. 2003
- Uptake of18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?. European Respiratory Journal European Respiratory Journal, Supplement. 21:848-854. 2003
- Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.. Thorax. 48:594-598. 1993
- Changes in the Cellular Profile of Induced Sputum after Allergen-induced Asthmatic Responses. American Review of Respiratory Disease. 145:1265-1269. 1992
-
conference paper
- DISTRIBUTION AND CLINICAL IMPACT OF CLONAL PSEUDOMONAS AERUGINOSA INFECTION IN THE CANADIAN CYSTIC FIBROSIS POPULATION. Pediatric Pulmonology. S339-S339. 2017
- PREDICTORS OF RESPONSE TO ANTIBIOTIC TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS. Pediatric Pulmonology. 355-355. 2014
- RANDOMIZED CONTROLLED TRIAL OF BIOFILM ANTIMICROBIAL SUSCEPTIBILITY TESTING IN PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION. Pediatric Pulmonology. 319-319. 2014
- Relationship Between Exacerbation Frequency And Clinical Outcomes In Patients With Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011
- TRANSLATING RESEARCH INTO PRACTICE: IMPLEMENTING A DECISION AID FOR ADULT CYSTIC FIBROSIS PATIENTS. Pediatric Pulmonology. 427-427. 2011
- Tissue Repair In Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2011
- Central Statistical Monitoring Of An International Thromboprophylaxis Trial. American Journal of Respiratory and Critical Care Medicine. 2010
- A Multicentre Pilot Randomized Trial of High Frequency Oscillation in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 2009
- Air Filtration for Childhood Asthma: A Pilot Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 2009
- Current High Frequency Oscillation (HFO) Utilization in Ontario.. American Journal of Respiratory and Critical Care Medicine. 2009
- Validation of the Asthma Control Questionnaire in Children.. American Journal of Respiratory and Critical Care Medicine. 2009
- CFOS trial: Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients. Journal of Bone and Mineral Research. S452-S452. 2007
- Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients.. Journal of Bone and Mineral Research. S416-S416. 2006
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.. Blood. 1784-1784. 2004
- High prevalence of fracture in young adults with cystic fibrosis.. Journal of Bone and Mineral Research. S294-S294. 2004
- Reliability study of APACHE II scores in a msICU. Critical Care Medicine. A68-A68. 2003